EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation

Moemi Iwasaki, Tadahiro Hashita, Eisei Hori, Sou Nakamura, Koji Eto, Yutaka Hashimoto, Tamihide Matsunaga, Takahiro Iwao

Journal of Pharmacological Sciences · 2026-10 · 162 (2) · 99-108

DOI: 10.1016/j.jphs.2026.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2026-10. Verfasst von Moemi Iwasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Ja…. Hauptthemen laut MEDLINE: Megakaryocytes, Thrombocytopenia, Sunitinib, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daiichi Sankyo Chemical Pharma Co Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MegakaryocytesThrombocytopeniaSunitinibCell ProliferationAntineoplastic AgentsHumansCell CyclePyrrolesGene ExpressionIndolesDown-RegulationCell Line

Stichwörter der Autor:innen

Cell cycleMegakaryocyteSunitinibThrombocytopeniaimMKCLs

Substanzen

SunitinibPyrrolesAntineoplastic AgentsIndoles

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan. Electronic address: moemi100505@gmail.com.
  • Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan. Electronic address: thashita@phar.nagoya-cu.ac.jp.
  • Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan. Electronic address: ehori@phar.nagoya-cu.ac.jp.
  • Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address: sou.nakamura@cira.kyoto-u.ac.jp.
  • Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. Electronic address: kojieto@cira.kyoto-u.ac.jp.
  • Department of Cell Biology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi, Kawasumi-cho, Mizuho-ku, Nagoya, 467-8601, Japan. Electronic address: hashimot@med.nagoya-cu.ac.jp.

Förderung

  • Daiichi Sankyo Chemical Pharma Co Ltd

Zitieren

APA

Iwasaki, M., Hashita, T., Hori, E., Nakamura, S., Eto, K., Hashimoto, Y., Matsunaga, T., & Iwao, T. (2026). Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation. Journal of Pharmacological Sciences, 162(2), 99-108. https://doi.org/10.1016/j.jphs.2026.07.002

Vancouver

Iwasaki M, Hashita T, Hori E, Nakamura S, Eto K, Hashimoto Y, et al. Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation. Journal of Pharmacological Sciences. 2026;162(2):99-108. doi:10.1016/j.jphs.2026.07.002

BibTeX
@article{Iwasaki2026,
  author = {Iwasaki, Moemi and Hashita, Tadahiro and Hori, Eisei and Nakamura, Sou and Eto, Koji and Hashimoto, Yutaka and Matsunaga, Tamihide and Iwao, Takahiro},
  title = {Sunitinib causes thrombocytopenia by suppressing megakaryocyte proliferation},
  journal = {Journal of Pharmacological Sciences},
  year = {2026},
  volume = {162},
  number = {2},
  pages = {99--108},
  doi = {10.1016/j.jphs.2026.07.002}
}
Kostenlos starten →